首页|基于液质联合技术对妊娠期糖尿病母儿非靶向代谢组学分析及子代相关性研究

基于液质联合技术对妊娠期糖尿病母儿非靶向代谢组学分析及子代相关性研究

扫码查看
目的 基于液质联合技术(liquid chromatography-mass spectrometry,LC-MS)对妊娠期糖尿病(gestational diabetes mellitus,GDM)进行母儿非靶向代谢组学及与子代相关性分析。方法 选取2022年1月至2022年11月本院足月择期剖宫产手术的GDM及健康妊娠者,分别作为GDM组(n=30)及对照组(n=30)。两组均取外周血和脐血,采用LC-MS法进行非靶向代谢组学分析,并比较两组的新生儿出生体重、血糖、血气分析、1分钟Apgar评分及不同时间胆红素。结果 ①GDM组和对照组母血、脐血的代谢中,负离子模式下,母血增加的代谢物有溶血磷脂酰胆碱18:2代谢物、聚乙烯等,减少的代谢物有3-氨基-1H-吡唑并[4,3-c]吡啶-4,6-二醇、N-二乙基十二胺等,脐血增加的代谢物有甘氨胆酸、十八烷酸等,减少的代谢物有1β-二甲基尿酸、3-羟基-2-辛基戊二酸等;②经偏最小二乘法判别分析显示,模型稳定可靠;③GDM组新生儿出生体重、出生血糖、24 h胆红素和48 h胆红素分别为(3 165。82±210。88)g、(4。56±0。36)mmol/L、(93。08±34。31)μmol/L 和(154。80±39。89)μmol/L,对 照 组 分 别 为(2 763。24±212。57)g、(4。06±0。40)mmol/L、(73。40±24。27)μmol/L 和(132。83±29。57)μmol/L,GDM 组新生儿上述指标均高于对照组(P<0。05)。结论 GDM母体血和脐血增加的代谢物可能影响胎儿生长发育,并推测与新生儿出生体重、出生血糖、24 h胆红素和48 h胆红素有关。
Non targeted metabonomic analysis of pregnant women and infants with diabetes mellitus and study on the correlation between their offspring based on liquid mass technology
Objective To conduct the maternal and fetal non targeted metabonomics analysis of gestational diabetes(GDM)based on liquid chromatography mass spectrometry(LC-MS),and to analyze the relationships between other indicators and offspring to guide the clinical data of GDM.Methods From January 2022 to November 2022,GDM and healthy pregnancy who underwent elective cesarean section at full term in the our hospital were selected and recorded as GDM group(n=30)and control group(n=30)respectively.Using LC-MS method,peripheral blood and umbilical cord blood were collected from both groups for non targeted metabolomics analysis,and the birth weight,blood glucose,blood gas analysis,1-minute Apgar scores and bilirubin at different moments of the two groups were compared.Results ® The main metabolites in maternal blood and cord blood in GDM group and control group increased metabolites in maternal blood included lysophosphatidylcholine 18:2 metabolite,polyethylene,etc,and the decreased metabolites included 3-amino-lH-pyrazolo[4,3-c]pyridine-4,6-diol,N-diethyldodecylamine,etc.Increased metabolites in cord blood included glycine cholic acid,octadecanoic acid,etc,and the decreased metabolites included 1,3-dimethyluric acid,3-hydroxy-2-octylglutaric acid,etc.® According to partial least squares discriminant analysis(PLS-DA),the model was stable and reliable.® The newborn birth weight,birth blood sugar,24-hour bilirubin,48-hour bilirubin in GDM group were(3 165.82±210.88)g,(4.56±0.36)mmol/L,(93.08±34.31)μmol/L and(154.80±39.89)μmol/L,which were(2 763.24±212.57)g,(4.06±0.40)mmol/L,(73.40±24.27)μmol/L and(132.83±29.57)μmol/L in the healthy control group,and those in the GDM group were higher than those in the healthy control group(P<0.05).Conclusions The increased metabolites in GDM maternal and cord blood may affect fetal growth and development,and it is guessed that they are speculated to be related to newborn birth weight,birth blood sugar,24-hour bilirubin,and 48-hour bilirubin.

liquid chromatography-mass spectrometrygestational diabetes mellitusmetabolomicsNeonates

蔡小桃、潘石蕾、李敏仪、卢沛超、袁林玉

展开 >

东莞市大朗医院产科,广东东莞 523000

南方医科大学珠江医院产科,广州 510000

液质联合技术 妊娠期糖尿病 代谢组学 新生儿

东莞市社会发展科技重点项目

20231800936192

2024

中国妇产科临床杂志
北京大学

中国妇产科临床杂志

CSTPCD北大核心
影响因子:1.095
ISSN:1672-1861
年,卷(期):2024.25(2)
  • 16